Establishment Glucose sensor on Apple Watch It is one of the most awaited updates by most of the device users. Although there is plenty of evidence that Apple is working on improving this feature, the unexpected departure of the project leader changed the evolution of this feature. And it was a few days ago Apple has found an executive who can take on this responsibility.

According to a post from 9to5mac, Apple has hired Tim Millet to oversee the team working on Apple’s non-invasive blood sugar monitoring technology. Millet has been a core member of Apple’s hardware technologies team for 19 years.

The new leader of the Apple Watch glucose sensor project

Millet was also a key component in Apple’s transition from Intel chips to Apple Silicon chips. In recent years. In addition to currently leading work on this new Apple Watch health feature, Millet is also “leading multiple teams behind the development of next-generation processors and other computing components.”

When will the experience of the nation and its team be useful? Optimize glucose monitor, part of Apple’s semiconductor organization and supports advanced chip-based system.

Until a few months ago, the most optimistic reports predicted that the glucose sensor would arrive with the launch of the Apple Watch in 2025. But other information in Mark Gurman’s “Power On” column stated: Sensor still needs to improve algorithms and integrated sensors to bring technology to market. All these changes, according to reliable analysts, “will last at least another three to seven years.”

Gurman also gave assurance Apple is ahead in developing a chip technology called “silicon photonics” with the process of “optical absorption spectroscopy.” These work by emitting wavelengths that can be absorbed by glucose into an area under the skin where interstitial fluid is located.

Apple has been experimenting with its blood sugar sensor for a decade. Bitten apples began developing this possibility after the acquisition of RareLight in 2010.. The company then used a startup called Avolante Health LLC to develop the technology in a secret facility before moving it to Exploration Design Group (XDG).